Suppliers and packagers for DAPZURA RT

DAPZURA RT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare Corp	DAPZURA RT	daptomycin	POWDER;INTRAVENOUS	213645	NDA	Baxter Healthcare Corporation	0338-0712-24	24 BAG in 1 CARTON (0338-0712-24) / 50 mL in 1 BAG	2022-01-25
Baxter Hlthcare Corp	DAPZURA RT	daptomycin	POWDER;INTRAVENOUS	213645	NDA	Baxter Healthcare Corporation	0338-0714-24	24 BAG in 1 CARTON (0338-0714-24) / 50 mL in 1 BAG	2022-01-25
Baxter Hlthcare Corp	DAPZURA RT	daptomycin	POWDER;INTRAVENOUS	213645	NDA	Baxter Healthcare Corporation	0338-0716-12	12 BAG in 1 CARTON (0338-0716-12) / 100 mL in 1 BAG	2022-01-25
Baxter Hlthcare Corp	DAPZURA RT	daptomycin	POWDER;INTRAVENOUS	213645	NDA	Baxter Healthcare Corporation	0338-0718-12	12 BAG in 1 CARTON (0338-0718-12) / 100 mL in 1 BAG	2022-01-25

Last updated: July 29, 2025

ppliers for the Pharmaceutical Drug: DAPZURA RT

Introduction

DAPZURA RT is a proprietary medication used primarily in the treatment of various gastrointestinal disorders, particularly diarrhea-predominant irritable bowel syndrome (IBS-D). Its active component, rifaximin, is a semi-synthetic, broad-spectrum antibiotic classified as a rifamycin derivative. The demand for rifaximin-based formulations like DAPZURA RT has risen globally, prompting pharmaceutical companies and suppliers to seek reliable sources for raw materials and finished products. This article elucidates the landscape of suppliers involved in the manufacturing and distribution of DAPZURA RT, analyzing their roles, market positioning, and strategic significance.

Overview of DAPZURA RT and Its Active Ingredient

DAPZURA RT contains rifaximin, a minimally absorbed antibiotic effective against gastrointestinal pathogens. It is manufactured via complex chemical synthesis processes that demand high standards for quality, purity, and compliance with regulatory frameworks such as the FDA, EMA, and other regional agencies. The supply chain involves multiple tiers: raw material suppliers, active pharmaceutical ingredient (API) producers, formulation manufacturers, and distributors.

**Key Suppliers of Rifaximin